VEGFA and hereditary elliptocytosis: The second part of our study was designed to extend the affirmative results from our proof-of-concept in vitro experiments to validate that VEGF/VEGFR2 signaling indeed plays a protective role against mitochondrial dysfunction in the RVLM that underpin high fatality associated with HE, using the AOM-treatment mouse model.